2 news items
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
CNTB
7 May 24
with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, today announced data from its global Phase
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
CNTB
16 Apr 24
with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, today reported financial results
- Prev
- 1
- Next